摘要:
A compound of Formula (I), or pharmaceutically acceptable salts and/or hydrates or prodrugs thereof, wherein Formula (I) has the structure: is provided, wherein R1-R7 are defined herein. These compounds are useful in medicaments for treating a disease selected from the group consisting of Alzheimer's disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject.
摘要:
A compound of Formula (I), or pharmaceutically acceptable salts and/or hydrates or prodrugs thereof, wherein Formula (I) has the structure: is provided, wherein R1-R7 are defined herein. These compounds are useful in medicaments for treating a disease selected from the group consisting of Alzheimer's Disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject.
摘要:
A compound of Formula (I), or pharmaceutically acceptable salts and/or hydrates or prodrugs thereof, wherein Formula (I) has the structure: is provided, wherein R1-R7 are defined herein. These compounds are useful in medicaments for treating a disease selected from the group consisting of Alzheimer's Disease, amyloid angiopathy, cerebral amyloid angiopathy, systemic amyloidosis, hereditary cerebral hemorrhage with amyloidosis of the Dutch type, inclusion body myositis, mild cognitive impairment (MCI) and Down's syndrome, in a subject.
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 化合物具有式Ia的结构:其中R 1是低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2, / 5> 5 R 5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R 2是低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R 3是氢,低级烷基或取代的低级烷基; R 4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; R 7是氢,卤素,低级烷基或取代的低级烷基。
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 所述化合物具有式Ia的结构:其中,R 1为低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2 R 5; R5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R2是低级烷基,取代的低级烷基,CF3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R3是氢,低级烷基或取代的低级烷基; R4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; 并且R 7是氢,卤素,低级烷基或取代的低级烷基。
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 所述化合物具有式Ia的结构:其中,R 1为低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2 R 5; R5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R2是低级烷基,取代的低级烷基,CF3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R3是氢,低级烷基或取代的低级烷基; R4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; 并且R 7是氢,卤素,低级烷基或取代的低级烷基。
摘要:
Compounds useful for lowering beta amyloid levels are provided. The compounds have the structure of formula Ia: wherein, R1 is lower alkyl, substituted lower alkyl, phenyl, substituted phenyl, benzyl, substituted benzyl, benzyloxy, substituted benzyloxy, or SO2R5; R5 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, alkyl, or substituted alkyl; R2 is lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, or cycloalkyl; R3 is hydrogen, lower alkyl, or substituted lower alkyl; R4 is phenyl, substituted phenyl, heterocycle, substituted heterocycle, thiophene, or substituted thiophene; R6 is hydrogen, lower alkyl, substituted lower alkyl, CF3, alkenyl, substituted alkenyl, alkynyl, substituted alkynyl, phenyl, substituted phenyl, cycloalkyl, or substituted cycloalkyl; W, X and Y are independently CR7 or N; and R7 is hydrogen, halogen, lower alkyl, or substituted lower alkyl.
摘要翻译:提供了可用于降低β淀粉样蛋白水平的化合物。 化合物具有式Ia的结构:其中R 1是低级烷基,取代的低级烷基,苯基,取代的苯基,苄基,取代的苄基,苄氧基,取代的苄氧基或SO 2, / 5> 5 R 5是苯基,取代的苯基,杂环,取代的杂环,烷基或取代的烷基; R 2是低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基或环烷基; R 3是氢,低级烷基或取代的低级烷基; R 4是苯基,取代的苯基,杂环,取代的杂环,噻吩或取代的噻吩; R 6是氢,低级烷基,取代的低级烷基,CF 3,烯基,取代的烯基,炔基,取代的炔基,苯基,取代的苯基,环烷基或取代的环烷基; W,X和Y独立地为CR 7或N; R 7是氢,卤素,低级烷基或取代的低级烷基。
摘要:
A method of selectively preparing a chiral 2S-amino alcohol useful in preparation of an amide sulfonated or acylated with alkyl, substituted aryl or substituted heteroaryl is described. The method involves reacting a di-tert-butyl diazene-1,2-dicarboxylate with a (4S)-4-benzyl-3-[(S)-trifluoromethyl-alkyl substituted alkanoyl]-1,3-oxazolidin-2-one to afford a di-tert-butyl 1-(1S,2S)-([(4S)-4-benzyl-2-oxo-1,3-oxazolidine-3-yl]-carbonyl}-trifluoromethyl-alkyl substituted alkyl)hydrazine-1,2-dicarboxylate. This dicarboxylate is then reduced to yield di-tert-butyl 1-(1S,2S)-[trifluoromethyl-alkyl substituted alkyl]hydrazine-1-(hydroxymethyl)-1,2-dicarboxylate. The resulting product is deblocked with an acid to yield the acid addition salt of (2S,3S)-trifluoro-hydrazino-methyl alkan-1-ol. The acid addition salt of (2S,3S)-trifluoro-2-hydrazino-methyl alkan-1-ol is hydrogenated in the presence of a suitable metal catalyst to yield the amino alcohol (2S,3S)-2-amino-trifluoro-methyl alkan-1-ol HCl.
摘要:
This invention provides novel tricyclic diazepine compounds as well as methods and pharmaceutical compositions utilizing these compounds for the treatment and/or prevention and/or suppression of disorders which may be remedied or alleviated by oxytocin antagonist activity, including treatment of preterm labor, dysmenorrhea, endometritis, and for suppressing labor prior to caesarean delivery. These compounds are also useful in enhancing fertility rates, enhancing survival rates and synchronizing estrus in farm animals; and may be useful in the prevention and treatment of disfunctions of the oxytocin system in the central nervous system including obsessive compulsive disorder (OCD) and neuropsychiatric disorders.
摘要:
This invention provides novel substituted tricyclic carboxamides which act as oxytocin receptor competitive antagonists, as well as methods of their manufacture, pharmaceutical compositions and methods of their use in treatment, inhibition, suppression or prevention of preterm labor, dysmenorrhea and endometritis, suppression of labor at term prior to caesarean delivery, and to facilitate antinatal transport to a medical facility. These compounds are also useful in enhancing fertility rates, enhancing survival rates and synchronizing estrus in farm animals; and may be useful in the prevention and treatment of disfunctions of the oxytocin system in the central nervous system including obsessive compulsive disorder (OCD) and neuropsychiatric disorders.